Vericel Provides Business and Financial Updates
April 02, 2020 09:00 ET
|
Vericel Corporation
First Quarter Preliminary Unaudited Product Revenues Increased Approximately 21% Over First Quarter 2019 Full Year 2020 Financial Guidance Withdrawn Due to Uncertainty Regarding Impact of COVID-19...
Vericel Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Full-Year 2020 Financial Guidance
February 25, 2020 08:00 ET
|
Vericel Corporation
Full Year 2019 Product Revenues of $117.9 Million Increased 30% Over 2018 Record Quarterly Revenue and Profit in the Fourth Quarter Conference Call Today at 8:30am Eastern Standard...
Vericel to Present at the 40th Annual Cowen Healthcare Conference on Monday, March 2, 2020
February 24, 2020 10:04 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel to Present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020
February 19, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel to Report Fourth-Quarter 2019 Financial Results on February 25, 2020
February 11, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel to Present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020
January 09, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that...
BARDA Initiates the Procurement of NexoBrid for Emergency Response
January 06, 2020 06:30 ET
|
Vericel Corporation
YAVNE, Israel and CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the U.S....
Vericel Announces Appointment of Sean C. Flynn as Vice President and General Counsel
November 06, 2019 09:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel Reports Record Third Quarter Revenues, Net Income and Operating Cash Flow
November 05, 2019 08:00 ET
|
Vericel Corporation
Product Revenues of $30.5 Million Increase 36% Over Third Quarter 2018Full Year 2019 Revenue Guidance Raised to $116 to $118 MillionConference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov....
Vericel to Report Third-Quarter 2019 Financial Results on November 5, 2019
October 22, 2019 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...